top of page
News
News
HOME
TEAM
NEWS & EVENTS
CONTACT
More
Use tab to navigate through the menu items.
ALL POSTS
PRESS RELEASES
NEWS
EVENTS
Search
Corsair Pharma Announces Successful Completion of Preclinical Program for Its Treprostinil Prodrug Transdermal System
Mar 17
Corsair Pharma Announces Appointment of George W. Mahaffey as Chief Executive Officer
Dec 11, 2023
Corsair Pharma Announces $23 Million Series B Financing to Advance Clinical Trials in PAH
Sep 20, 2023
Corsair Pharma to Host Key Opinion Leader Meeting on Pulmonary Arterial Hypertension
Jun 24, 2021
Corsair & United Therapeutics Enter Strategic Collaboration to Advance Novel Treprostinil Prodrugs
Jan 3, 2018
bottom of page
